AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33415790 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive dissonance microintervention
Number of subjects: 202
Study 33415790 — intervention group
Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 202
Study 32534502 — intervention group
Group type: EXPERIMENTAL
Intervention: GA‐VIBE MRI sequence
Number of subjects: 11
Study 32534502 — intervention group
Group type: COMPARATOR
Intervention: CT scans
Number of subjects: 11
Study 33840341 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual removal of the placenta with intrauterine cleaning (n = 110)
Number of subjects: 436
Study 33840341 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual removal of the placenta without intrauterine cleaning (n = 106)
Number of subjects: 436
Study 33840341 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous placental delivery with intrauterine cleaning (n = 108)
Number of subjects: 436
Study 33840341 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous placental delivery without intrauterine cleaning (n = 112)
Number of subjects: 436
Study 33471196 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgenic cowpea plants expressing Cry2Aa protein
Number of subjects: 11
Study 33471196 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-transgenic cowpea plants)
Number of subjects: 11
Study 35501278 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV)
Number of subjects: 0
Study 35501278 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32045103 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF‐gel treatment
Number of subjects: 20
Study 36396600 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive moderate-vigorous elastic resistance training (2 days/week for 8 weeks)
Number of subjects: 20
Study 36396600 — intervention group
Group type: COMPARATOR
Intervention: Usual daily activities (control group)
Number of subjects: 20
Study 32700151 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic feedback
Number of subjects: 0
Study 32700151 — intervention group
Group type: COMPARATOR
Intervention: No haptic feedback
Number of subjects: 0
Study 32108890 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined Lp(a) levels
Number of subjects: 139362
Study 32108890 — intervention group
Group type: EXPERIMENTAL
Intervention: LPA single-nucleotide polymorphisms
Number of subjects: 139362
Study 32108890 — intervention group
Group type: EXPERIMENTAL
Intervention: Lp(a) levels equal to or above the 95th percentile
Number of subjects: 139362
Study 35293287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus brivaracetam 100 mg
Number of subjects: 24
Study 35293287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion brivaracetam 100 mg
Number of subjects: 24
Study 35293287 — intervention group
Group type: COMPARATOR
Intervention: Oral reference tablet brivaracetam 100 mg
Number of subjects: 24
Study 33606908 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi once daily
Number of subjects: 887
Study 33606908 — intervention group
Group type: COMPARATOR
Intervention: BIAsp 30 twice daily
Number of subjects: 887
Study 32825849 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 808
Study 32825849 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 808
Study 32825849 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 808
Study 32825849 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin
Number of subjects: 808
Study 32825849 — intervention group
Group type: EXPERIMENTAL
Intervention: All AMs combined
Number of subjects: 808
Study 32825849 — intervention group
Group type: EXPERIMENTAL
Intervention: General AM use
Number of subjects: 808
Study 35300622 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention (low-frequency rTMS and cathodal tDCS)
Number of subjects: 10
Study 35300622 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 10
Study 34716033 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic physical activity intervention (14-week, 4 lessons per week)
Number of subjects: 62
Study 34716033 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively-engaging physical activity intervention (14-week, 4 lessons per week)
Number of subjects: 62
Study 34716033 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular program, 2 lessons per week)
Number of subjects: 62
Study 34716033 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (aerobic, cognitively-engaging, control)
Number of subjects: 62
Study 34601896 — intervention group
Group type: EXPERIMENTAL
Intervention: PCSK9 association with HDL
Number of subjects: 656
Study 34601896 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial response studies
Number of subjects: 656
Study 34601896 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL proteome analysis
Number of subjects: 656
Study 34601896 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanistic study of HDL and PCSK9
Number of subjects: 656
Study 35844458 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 7% sevoflurane and intravenous infusion of remifentanil
Number of subjects: 60
Study 35844458 — intervention group
Group type: COMPARATOR
Intervention: Inhalation of 7% sevoflurane
Number of subjects: 60
Study 33694325 — intervention group
Group type: EXPERIMENTAL
Intervention: Stylosanthes hamata (SH)
Number of subjects: 200
Study 33694325 — intervention group
Group type: COMPARATOR
Intervention: Deep litter (DL)
Number of subjects: 200
Study 33694325 — intervention group
Group type: EXPERIMENTAL
Intervention: Stylosanthes hamata (SH), Stylosanthes guanensis (SG), Mucuna pruriens (MP)
Number of subjects: 200
Study 33694325 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep litter (DL) and free run (FR)
Number of subjects: 200
Study 33694325 — intervention group
Group type: EXPERIMENTAL
Intervention: Legume pastures
Number of subjects: 200
Study 35041082 — intervention group
Group type: EXPERIMENTAL
Intervention: EBPT
Number of subjects: 60
Study 35041082 — intervention group
Group type: COMPARATOR
Intervention: PO-EBPT
Number of subjects: 60
Study 34537218 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-Care Testing (POCT)
Number of subjects: 380
Study 34537218 — intervention group
Group type: COMPARATOR
Intervention: Central laboratory
Number of subjects: 380
Study 33871235 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated group (with occlusal splint)
Number of subjects: 16
Study 33871235 — intervention group
Group type: COMPARATOR
Intervention: Control group (Untreated)
Number of subjects: 16
Study 33871235 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (lower plaque without occlusal coverage)
Number of subjects: 16
Study 32854761 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline therapy plus TCMR (acupressure therapy and Liu Zi Jue Qigong exercises)
Number of subjects: 128
Study 32854761 — intervention group
Group type: COMPARATOR
Intervention: Guideline therapy (control group)
Number of subjects: 128
Study 35940019 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 76
Study 35940019 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 76
Study 35940019 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 76
Study 33476482 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to infection control and prevention (ICP) guidelines
Number of subjects: 552
Study 33476482 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to wearing medical masks, gloves, and hand hygiene practices
Number of subjects: 552
Study 33476482 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors contributing to high-risk exposure
Number of subjects: 552
Study 32551271 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation adenoidectomy
Number of subjects: 70
Study 32551271 — intervention group
Group type: COMPARATOR
Intervention: Conventional adenoidectomy
Number of subjects: 70
Study 35482125 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-release surgery
Number of subjects: 62
Study 35482125 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided tendon dry needling
Number of subjects: 62
Study 33798466 — intervention group
Group type: EXPERIMENTAL
Intervention: Volanesorsen (300 mg subcutaneously once a week for 26 weeks, then every 2 weeks)
Number of subjects: 114
Study 33798466 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1.5 mL subcutaneously once a week for 26 weeks, then every 2 weeks)
Number of subjects: 114
Study 33798466 — intervention group
Group type: EXPERIMENTAL
Intervention: Volanesorsen
Number of subjects: 114
Study 33798466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 36400420 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapartum ultrasound for labor progress assessment
Number of subjects: 182
Study 33334727 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 498
Study 33334727 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 498
Study 33334727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 498
Study 32242480 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency external muscle stimulation
Number of subjects: 22
Study 32242480 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 22
Study 33137579 — intervention group
Group type: EXPERIMENTAL
Intervention: SPEEDI intervention (10 therapy sessions until 3 months' corrected age, 5 hospital sessions and 5 home-based sessions)
Number of subjects: 17
Study 33137579 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 17
Study 36484441 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-μg TAK-426 vaccine
Number of subjects: 0
Study 36484441 — intervention group
Group type: COMPARATOR
Intervention: Natural infection
Number of subjects: 0
Study 34211101 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoneuromodulation (PNM) stimulation applied to the forehead
Number of subjects: 33
Study 34211101 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 33
Study 34904903 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion during cardiopulmonary bypass
Number of subjects: 70
Study 34904903 — intervention group
Group type: COMPARATOR
Intervention: Non-pulsatile perfusion during cardiopulmonary bypass
Number of subjects: 70
Study 34351598 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary decision support for CT imaging of patients with head injuries
Number of subjects: 225
Study 34351598 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary decision support for CT imaging of patients with suspected pulmonary embolism
Number of subjects: 225
Study 36150063 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline pain
Number of subjects: 7237
Study 36150063 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline elevated depressive symptoms
Number of subjects: 7237
Study 33858553 — intervention group
Group type: EXPERIMENTAL
Intervention: Empiric antibiotics for MRSA infection
Number of subjects: 0
Study 33858553 — intervention group
Group type: COMPARATOR
Intervention: Non-MRSA antibiotics
Number of subjects: 0
Study 32800062 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-world evidence (RWE)
Number of subjects: 0
Study 32800062 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 34614379 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid MenACWY-CRM vaccine presentation stored for approximately 24 months
Number of subjects: 1690
Study 34614379 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid MenACWY-CRM vaccine presentation stored for approximately 30 months
Number of subjects: 1690
Study 34614379 — intervention group
Group type: COMPARATOR
Intervention: Licensed lyophilized/liquid MenACWY-CRM vaccine presentation
Number of subjects: 1690
Study 33887722 — intervention group
Group type: EXPERIMENTAL
Intervention: MedTest Coronavirus (COVID-19) IgG/IgM
Number of subjects: 119
Study 33887722 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 IgG/IgM ECO Test
Number of subjects: 119
Study 33887722 — intervention group
Group type: EXPERIMENTAL
Intervention: Camtech COVID-19 IgM/IgG Rapid Test Kit
Number of subjects: 119
Study 33887722 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-Step COVID-19 Test for total antibodies
Number of subjects: 119
Study 33887722 — intervention group
Group type: EXPERIMENTAL
Intervention: Wondfo test
Number of subjects: 119
Study 33887722 — intervention group
Group type: COMPARATOR
Intervention: Probable SARS-CoV-2 infection cases
Number of subjects: 119
Study 32169137 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber reinforced composite (FRC) retainers
Number of subjects: 54
Study 32169137 — intervention group
Group type: COMPARATOR
Intervention: Multistranded stainless steel (MSW) retainers
Number of subjects: 54
Study 35377919 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health-focused intervention
Number of subjects: 723
Study 34778734 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) PEP (400/100 mg) twice daily for 5 days
Number of subjects: 318
Study 34778734 — intervention group
Group type: COMPARATOR
Intervention: Surveillance (no PEP)
Number of subjects: 318
Study 34778734 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) PEP
Number of subjects: 318
Study 35987857 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert assessment of shoulder impairments followed by an individualised treatment plan
Number of subjects: 130
Study 35987857 — intervention group
Group type: COMPARATOR
Intervention: Minimal physiotherapeutic rehabilitation program delivered in a pamphlet
Number of subjects: 130
Study 35648426 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG solution (660 μmol/L)
Number of subjects: 180
Study 35648426 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl saline)
Number of subjects: 180
Study 34365061 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis (500 mg/day)
Number of subjects: 40
Study 34365061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32859661 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention to increase high-nitrate vegetable consumption and reduce salt intake over 6 months
Number of subjects: 0
Study 32859661 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 0
Study 34342807 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app-directed and nurse-supported self-management intervention
Number of subjects: 30
Study 34342807 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 32128877 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose SIM (200 mg)
Number of subjects: 400
Study 32128877 — intervention group
Group type: COMPARATOR
Intervention: High-dose SIM (1200 mg)
Number of subjects: 400
Study 35638295 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowband ultraviolet B (NB-UVB) phototherapy
Number of subjects: 30
Study 35638295 — intervention group
Group type: COMPARATOR
Intervention: Placebo phototherapy
Number of subjects: 30
Study 34028866 — intervention group
Group type: EXPERIMENTAL
Intervention: EMPWR program (2-session STI risk reduction program)
Number of subjects: 150
Study 32390721 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-exercise maltodextrin (2g/kg)
Number of subjects: 0
Study 32390721 — intervention group
Group type: COMPARATOR
Intervention: Control (no maltodextrin)
Number of subjects: 0
Study 35834000 — intervention group
Group type: EXPERIMENTAL
Intervention: Mozart's music during toothbrushing training
Number of subjects: 60
Study 35834000 — intervention group
Group type: COMPARATOR
Intervention: No music during toothbrushing training
Number of subjects: 60
Study 34453358 — intervention group
Group type: EXPERIMENTAL
Intervention: guselkumab 100 mg
Number of subjects: 133
Study 34453358 — intervention group
Group type: EXPERIMENTAL
Intervention: guselkumab 200 mg
Number of subjects: 133
Study 34453358 — intervention group
Group type: COMPARATOR
Intervention: guselkumab 100 mg (after placebo)
Number of subjects: 133
Study 34453358 — intervention group
Group type: COMPARATOR
Intervention: guselkumab 200 mg (after placebo)
Number of subjects: 133
Study 34453358 — intervention group
Group type: EXPERIMENTAL
Intervention: guselkumab (both dosages)
Number of subjects: 133
Study 35875346 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic tablets (500 mg, 2 tab/day)
Number of subjects: 91
Study 35875346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 32594587 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy (CFT)
Number of subjects: 206
Study 32594587 — intervention group
Group type: COMPARATOR
Intervention: Group exercise and education intervention
Number of subjects: 206
Study 33333526 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Management Program (SMP)
Number of subjects: 59
Study 34110699 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral deployment of HILZO Moving Cell Stents (MCS) using stent-in-stent (SIS) technique
Number of subjects: 27
Study 35179588 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal intubation (ETI)
Number of subjects: 936
Study 35179588 — intervention group
Group type: COMPARATOR
Intervention: Supraglottic airway (SGA)
Number of subjects: 936
Study 34849433 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube introducer (ETI) for right selective intubation
Number of subjects: 46
Study 34849433 — intervention group
Group type: COMPARATOR
Intervention: No endotracheal tube introducer for right selective intubation
Number of subjects: 46
Study 34849433 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube introducer (ETI) for left selective intubation
Number of subjects: 46
Study 34849433 — intervention group
Group type: COMPARATOR
Intervention: No endotracheal tube introducer for left selective intubation
Number of subjects: 46
Study 32540088 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (organization training, self-management, note-taking instruction)
Number of subjects: 64
Study 32540088 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (students willing to follow procedures)
Number of subjects: 64
Study 32540088 — intervention group
Group type: COMPARATOR
Intervention: Accommodation group (organization support, extended time, copy of teacher notes)
Number of subjects: 64
Study 35436153 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTX)
Number of subjects: 191
Study 35436153 — intervention group
Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 191
Study 33849353 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity with cognitive demand (EXCIR)
Number of subjects: 30
Study 33849353 — intervention group
Group type: COMPARATOR
Intervention: Physical activity without cognitive demand (running, aerobic exercise)
Number of subjects: 30
Study 32182098 — intervention group
Group type: COMPARATOR
Intervention: Usual care (COPD discharge bundle including PR information leaflet)
Number of subjects: 196
Study 32182098 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus the codesigned education video delivered via a handheld tablet device at discharge
Number of subjects: 196
Study 34628152 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal program including mindfulness-based practices, expressive arts, and EMDR group treatment
Number of subjects: 44
Study 34628152 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual control group
Number of subjects: 44
Study 32575124 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (400 mg dose)
Number of subjects: 27
Study 34008278 — intervention group
Group type: EXPERIMENTAL
Intervention: High-voltage, long-duration pulsed radiofrequency (HL-PRF)
Number of subjects: 120
Study 34008278 — intervention group
Group type: COMPARATOR
Intervention: Standard pulsed radiofrequency (S-PRF)
Number of subjects: 120
Study 33122540 — intervention group
Group type: EXPERIMENTAL
Intervention: SLAMM+ (multicomponent intervention with height-adjustable workstations)
Number of subjects: 0
Study 33122540 — intervention group
Group type: COMPARATOR
Intervention: SLAMM (multicomponent intervention without height-adjustable workstations)
Number of subjects: 0
Study 32366452 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV)
Number of subjects: 90
Study 32366452 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed (PEM)
Number of subjects: 90
Study 32366452 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus Pemetrexed (BEV+PEM)
Number of subjects: 90
Study 35533197 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 0.125 M L‐glutamic acid at 1.65 mL/kg/h
Number of subjects: 303
Study 35533197 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 303
Study 35533197 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 0.125 M L‐glutamic acid at 1.65 mL/kg/h (in patients without diabetes)
Number of subjects: 303
Study 35533197 — intervention group
Group type: COMPARATOR
Intervention: Saline (control, in patients without diabetes)
Number of subjects: 303
Study 35533197 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 0.125 M L‐glutamic acid
Number of subjects: 303
Study 34496276 — intervention group
Group type: EXPERIMENTAL
Intervention: One avocado per day for six months
Number of subjects: 1008
Study 34496276 — intervention group
Group type: COMPARATOR
Intervention: Usual diet essentially devoid of avocados
Number of subjects: 1008
Study 36126237 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot massage (once every day for 7 days)
Number of subjects: 70
Study 36126237 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 70
Study 33198629 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Monitoring (RM)
Number of subjects: 55
Study 33198629 — intervention group
Group type: COMPARATOR
Intervention: Conventional Monitoring (CM)
Number of subjects: 55
Study 35045999 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) applied immediately after extubation combined with high-flow nasal oxygen (HFNO) or standard oxygen between NIV sessions
Number of subjects: 0